We offer a novel topical treatment for ocular degeneration that restores neuronal function and vision with a simple eye drop.

Occult Tethered Cord Syndrome (TCS) is a serious medical condition often detected before birth. If the spinal cord is not free it can result in several other urological problems and can result in a life-long disability.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

University of Arizona researchers have developed a safe, edible food sanitizer to eliminate both foodborne and spoilage microorganisms, greatly reducing food illnesses and increasing shelf-life.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

Precision anti-infective technology focused on a microbiome sparing strategy. We target Clostridioides difficile infection (CDI), an antibiotic-associated infectious diarrheal disease, through oral delivery of a targeted Antisense Oligonucleotide.

The Atmospherica process utilizes naturally occurring, photosynthetic, shell-forming micro-algae to sequester CO2 and store it as calcium carbonate, a highly durable mineral that is stable for millions of years. It is a safe and relatively easy process that can be implemented quickly and cost effectively.

Our novel gene editing removes the immunogenicity of human Pluripotent Stem Cells upon implantation into human organs. We have chosen Type 1 Diabetes as the initial indication to demonstrate the potential of our platform.